Skip to Content

Franklin Biotechnology Discovery A FBDIX

Analyst rating as of | See Franklin Templeton Investment Hub
  • NAV / 1-Day Return 112.43  /  0.36 %
  • Total Assets 833.5 Mil
  • Adj. Expense Ratio
  • Expense Ratio 1.040%
  • Distribution Fee Level Low
  • Share Class Type Front Load
  • Category Health
  • Investment Style Mid Growth
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 0.13%
  • Turnover 26%

Morningstar’s Analysis FBDIX

Will FBDIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

An expanding universe presents challenges.

Senior Analyst



Franklin Biotechnology Discovery is overseen by experienced managers, but limited resources and an undifferentiated process earn the fund a Morningstar Analyst Rating of Neutral.

Unlock our full analysis with Morningstar Investor